 Disease Information - November 21, 2008
|
The U.S. Food and Drug Administration endorses expanding of the pool of people who use the popular cholesterol drug, Lipitor. The drug is currently used to decrease the risk of strokes and heart attacks in diabetics, who also have risk factors for heart disease |
|
The Food and Drug Administration endorses expanding of the pool of people who use the popular cholesterol drug Lipitor |
|
A new therapy for the treatment of recurrent breast cancer is announced by BSD Medical Corporation on Tuesday, bringing hope to survivors of the deadly disease. The reported study conducted at Duke University Medical Center showed a near triple rate of tumor elimination for recurrent breast cancer when this therapy was added to conventional radiation therapy |
|
Hector Duarte Jr. - All Headline News Staff Reporter Scientists at the Centers for Disease Control and Prevention and at the University of Florida find the sick dogs' disease almost identical to the H3N8 influenza strain that afflicts horses |
|
The U.S. Food and Drug Administration is fast tracking a new drug named "arimoclomol", for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). Pharmaceutical giant, CytRx, announces the initiation of a phase II clinical trial with orally-administered arimoclomol for ALS, and patient identification for this trial, which currently is underway at several clinical trial sites. Arimoclomol was granted orphan drug status designation by the FDA for the treatment of ALS in May 2005 |
|